Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Electronic Journal of Biotechnology(2)
American Chemical Society, Polymer Preprints, Division of Polymer Chemistry(1)
BMC Cancer(1)
Biotecnologia Aplicada(1)
FEBS Letters(1)
A synthetic conjugate polysaccharide vaccine against haemophilus influenzae type b
ArticleAbstract: Glycoconjugate vaccines provide effective prophylaxis against bacterial infections. To date, howeverPalabras claves:Autores:Aguilar A., Baly A., Campa C., Cardoso F., Carmenates A., Cosme K., Costa L., Deler M.L., Diaz M., Eugenio Hardy, Fernández-Santana V., Garcia E., Hernández I., Herrera L., Heynngnezz L., Izquierdo M., Medina E., Montane M., Muzachio A., Ramos A., Rodriguez A., Rodriguez M.C., Roy R., Sánchez R., Sosa I., Toledo-Romani M.E., Toraño G., Valdés Y., Verez-Bencomo V., Villar A.Fuentes:scopusDevelopment of semisolid preparations for topical delivery of epidermal growth factor
Conference ObjectAbstract: Epidermal growth factor (EGF) is an endogenous protein of 53 amino acids residues isolated from submPalabras claves:Autores:Aguilera A., Berlanga-Acosta J., Eugenio Hardy, Garcia O., Herrera L., Lazcano R.R., Lorenzo R.R., Ramos L.Fuentes:scopusCIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo
ArticleAbstract: Protein Kinase CK2 is a serine-threonine kinase frequently deregulated in many human tumors. Here, wPalabras claves:apoptosis, Cancer targeted therapy, Casein kinase 2Autores:Acevedo B.E., Alonso D.F., Ariosa J., Bacardí D.M., Baladron I., Besada-Pérez V., Betancourt L., Castellanos L.R., Cosme K., Cruz M., Díaz A., Falcón-Cama V., Farina H., Garay H.E., Gil J., Gómez D., Gómez R., González L.J., Hernández I., Herrera L., López C., López-Mola E., López-Saura P.A., Marcelo J.L., Mendoza O., Perea-Rodríguez S.E., Perera Y., Puchades Y., Reyes O., Rodriguez A., Sánchez A., Santana A., Serrano J.M., Sigman H., Silva R., Solares M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusExpression and folding of an interleukin-2-proinsulin fusion protein and its conversion into insulin by a single step enzymatic removal of the C-peptide and the N-terminal fused sequence
ArticleAbstract: We report the expression in E. coli of a proinsulin fusion protein carrying a modified interleukin-2Palabras claves:Enzymatic processing, Proinsulin folding, Recombinant insulinAutores:Besada-Pérez V., Castellanos‐Serra L., Eugenio Hardy, Falcón-Cama V., Fernandez C., Gonzalez M., Herrera L., Perez G., Santiago Nelson Vispo, Santos-Savio A., Silva A., Ubieta R.Fuentes:scopusExpression of il-2/proinsulin fusion protein: Folding of the fusion protein and conversion into insulin by a one step removal of c-peptide and leader sequence
ArticleAbstract:Palabras claves:Autores:Besada-Pérez V., Castellanos L.R., Estrada R., Eugenio Hardy, Fernandez C., Gonzalez M., Herrera L., Jimenez V., Perez G., Santiago Nelson Vispo, Silva A., Ubieta R.Fuentes:scopusIntramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
ArticleAbstract: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenicPalabras claves:Collateral development, Coronary artery disease, Gene therapy, Naked plasmid DNA, revascularization, Therapeutic angiogenesisAutores:Alí A., Batista J.F., Chaos N., Coca M., Dominguez H., Garcia-Osuna T., González N., González R., Guevara L., Herrera L., Montequín J.F., Ojalvo A.G., Perera A., Puchades Y., Quián Y.P., Reima C., Reyes J.L., Santiago Nelson Vispo, Seralena A., Silva R., Vazquez R.Fuentes:scopusMolecular characterization of recombinant human interferon alpha-2b produced in Cuba
ArticleAbstract: The recombinant human interferon α 2b (IFN-γ(2b)) produced by Cuban technology is obtained from EschPalabras claves:IFN, Molecular characterization, Recombinant human interferon alfa 2bAutores:Beldarrain A., Besada-Pérez V., Betancourt L., Brito R., Curras T., Eugenio Hardy, Ferrero J., Gil M., González L.J., Herrera L., Huerta V., Martinez E., Moya G., Pujols V., Sanchez J.C., Santana-Milián H., Sosa R., Vivian Morera CórdovaFuentes:googlescopusSafety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies
ArticleAbstract: Background: Cervical cancer is now considered the second leading cause of death among women worldwidPalabras claves:Autores:Acevedo B.E., Alonso D.F., Baladron I., Castillo D., Díaz A., Gómez R., González C.A., Herrera L., López-Saura P.A., Perea-Rodríguez S.E., Santana A., Sigman H., Solares A.M., Thelvia I. Ramos Gómez, Valenzuela-Silva C.M.Fuentes:googlescopusTherapeutic angiogenesis following intramuscular gene transfer of vascularendothelial growth factor 121 in a dog model of hindlimb ischemia
ArticleAbstract: Vascular endothelial growth factor (VEGF), an endothelial cell-specific mitogen, has been shown to pPalabras claves:Collateral development, Gene therapy, Naked plasmid DNA, Peripheral vascular disease, revascularizationAutores:Aldama A., Alfonso M.A., Alí A., Herrera L., López-Saura P.A., Montequín J.F., Ojalvo A.G., Puchades Y., Santiago Nelson Vispo, Seralena A., Seuc A., Silva R., Simón R., Sorell L.T., Vazquez R.Fuentes:scopus